Dr. Lal PathLabs Limited

NSEI:LALPATHLAB Stock Report

Market Cap: ₹195.1b

Dr. Lal PathLabs Management

Management criteria checks 2/4

Dr. Lal PathLabs' CEO is Bharath Uppiliappan, appointed in Apr 2020, has a tenure of 4.08 years. directly owns 0.015% of the company’s shares, worth ₹29.37M. The average tenure of the management team and the board of directors is 4.1 years and 5.1 years respectively.

Key information

Bharath Uppiliappan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.1yrs
CEO ownership0.02%
Management average tenure4.1yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

May 01
What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Apr 13
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Mar 06
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Feb 04
Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Dec 28
Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Nov 17
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Oct 12
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Jul 07
Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 10
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Feb 13
Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dec 29
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

Sep 21
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Sep 01
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Jul 31
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 23
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

May 25
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?

Apr 28
Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?

Is Dr. Lal PathLabs (NSE:LALPATHLAB) A Risky Investment?

Feb 17
Is Dr. Lal PathLabs (NSE:LALPATHLAB) A Risky Investment?

With EPS Growth And More, Dr. Lal PathLabs (NSE:LALPATHLAB) Is Interesting

Jan 20
With EPS Growth And More, Dr. Lal PathLabs (NSE:LALPATHLAB) Is Interesting

Why You Should Care About Dr. Lal PathLabs' (NSE:LALPATHLAB) Strong Returns On Capital

Dec 06
Why You Should Care About Dr. Lal PathLabs' (NSE:LALPATHLAB) Strong Returns On Capital

Here's Why I Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today

Oct 13
Here's Why I Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today

CEO

Bharath Uppiliappan

4.1yrs

Tenure

Mr. Bharath Uppiliappan has been Chief Executive Officer of Dr. Lal PathLabs Limited since April 1, 2020. He served as CEO of India Business at Dr. Lal PathLabs Limited since 2018 until April 1, 2020 and h...


Leadership Team

NamePositionTenureCompensationOwnership
Arvind Lal
Executive Chairman29.3yrs₹28.24m33.48%
₹ 65.3b
Om Manchanda
MD & Director4.1yrs₹44.42m1.16%
₹ 2.3b
Vandana Lal
Executive Directorno data₹22.65m19.36%
₹ 37.8b
Bharath Uppiliappan
Chief Executive Officer4.1yrsno data0.015%
₹ 29.4m
Ved Goel
Group Chief Financial Officer5.8yrs₹7.30m0.012%
₹ 22.9m
Jai Meena
Chief Operating Officer2.1yrsno datano data
Munender Soperna
Chief Information & Digital Officer9.9yrsno data0.034%
₹ 65.8m
Vinay Gujral
Company Secretary & Compliance Officer1.1yrsno datano data
Manoj Garg
Group Chief Human Resources Officer9.6yrsno data0.037%
₹ 72.1m
Shankha Banerjee
Chief Executive Officer of Group & Associates Companiesno datano data0.033%
₹ 64.0m

4.1yrs

Average Tenure

62.5yo

Average Age

Experienced Management: LALPATHLAB's management team is considered experienced (4.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Arvind Lal
Executive Chairman29.3yrs₹28.24m33.48%
₹ 65.3b
Om Manchanda
MD & Director13.3yrs₹44.42m1.16%
₹ 2.3b
Vandana Lal
Executive Director29.3yrs₹22.65m19.36%
₹ 37.8b
Arun Duggal
Lead Independent Director1.3yrs₹250.00kno data
Rajit Mehta
Independent Directorless than a yearno datano data
Rahul Sharma
Non Executive Director18.8yrs₹1.87m0.037%
₹ 71.7m
Rohit Bhasin
Independent Non-Executive Director1.5yrs₹770.00kno data
Somya Satsangi
Independent Director5.3yrs₹2.13mno data
Archana Erdmann
Non-Executive Director5yrs₹1.47m2.04%
₹ 4.0b
Gurinder Singh Kalra
Independent Directorless than a yearno datano data

5.1yrs

Average Tenure

62yo

Average Age

Experienced Board: LALPATHLAB's board of directors are considered experienced (5.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.